Fundz

Cura Sen Therapeutics reported raising $5.79 Million in an initial SEC Form D filing, from an offering of $45.7 Million

PRIVATESep 18, 2024$5.8M of $45.7M raised

Amount Raised

$5.79 Million

$5.79 Million sold, per SEC Form D (first sale Aug 26, 2024)

Round Type

Venture

San CarlosBiotechnology

Quick answer

CuraSen Therapeutics raised $5.79 Million in a funding round, dated August 26, 2024. CuraSen Therapeutics is based in San Carlos, California, United States.

How much did CuraSen Therapeutics raise?
CuraSen Therapeutics raised $5.79 Million in a funding round on August 26, 2024.
What does CuraSen Therapeutics do?
CuraSen Therapeutics, Inc. is a privately funded biopharmaceutical company pursuing development of novel treatments for neurodegenerative diseases, including Parkinson’s disease and Alzheimer’s disease, as well as..
Where is CuraSen Therapeutics based and how big is it?
CuraSen Therapeutics is based in San Carlos, California, United States.
Who are the decision-makers at CuraSen Therapeutics?
Fundz holds 1 contact at CuraSen Therapeutics, including the Director, Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as CuraSen Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Booster Therapeutics raised $15M (Angel) on October 10, 2024.
  • Orasis Pharmaceuticals raised $78M (Series D) on October 10, 2024.
  • MiLaboratories raised $10M (Series A) on October 10, 2024.
  • Holobiome raised an undisclosed amount (Seed) on October 10, 2024.
  • baCta raised $3.6M (Pre-Seed) on October 10, 2024.
  • Cytovale raised $100M (Series D) on October 10, 2024.

Who to call at CuraSen Therapeutics, and when

A new round usually means CuraSen Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day CuraSen Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CuraSen Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CuraSen Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

CuraSen Therapeutics

Location

733 Industrial Road

San Carlos, California, United States

About

CuraSen Therapeutics, Inc. is a privately funded biopharmaceutical company pursuing development of novel treatments for neurodegenerative diseases, including Parkinson’s disease and Alzheimer’s disease, as well as several orphan indications. Millions of patients and their families are burdened by these diseases, and the numbers continue to grow annually with the aging population.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment CuraSen Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsAnthony F., Director, Executive Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for CuraSen Therapeutics's next move

See what Strategic adds

CuraSen Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.